|
1. Mendes RA, Carvalho JF, van der Waal I.
Biological pathways involved in the aggressive behavior of the keratocystic odontogenic
tumor and possible implications for molecular oriented treatment - an
overview. Oral
Oncol. 2010;46:19-24.
http://dx.doi.org/10.1016/j.oraloncology.2009.10.009
PMid:20004133
|
|
|
|
2.
Mateus GC, Lanza GH, de Moura
PH, Marigo Hde A, Horta MC. Cell
proliferation and apoptosis in keratocystic odontogenic tumors. Med Oral Patol
Oral Cir Bucal. 2008;13:E697-702.
PMid:18978709
|
|
|
|
3. Maurette
PE, Jorge J, de Moraes M. Conservative treatment
protocol of odontogenic keratocyst:
a preliminary study. J
Oral Maxillofac Surg.
2006;64:379-83.
http://dx.doi.org/10.1016/j.joms.2005.11.007
PMid:16487797
|
|
|
|
4. Browne RM. The odontogenic keratocyst.
Clinical aspects. Br Dent J. 1970;128:225-31.
http://dx.doi.org/10.1038/sj.bdj.4802449
PMid:5270271
|
|
|
|
5. Madras J, Lapointe H. Keratocystic odontogenic tumour:
reclassification of the odontogenic keratocyst from cyst to tumour.
J
Can Dent Assoc. 2008;74:165-65h.
PMid:18353202
|
|
|
|
6.
Johann AC, Caldeira PC, Caliari
MV, Gomez RS, Aguiar
MC, Mesquita RA. Metallothionein immunoexpression in non-syndromic and syndromic keratocystic odontogenic tumour. Med Oral Patol Oral
Cir Bucal. 2015;20:e408-12.
http://dx.doi.org/10.4317/medoral.20418
PMid:25858080 PMCid:PMC4523252
|
|
|
|
7. Mendes RA, Carvalho JF, van der Waal I.
Characterization and management of the keratocystic
odontogenic tumor in relation to its histopathological and biological features. Oral Oncol. 2010;46:219-25.
http://dx.doi.org/10.1016/j.oraloncology.2010.01.012
PMid:20189443
|
|
|
|
8. Shear M. The
aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 2.
Proliferation and genetic studies. Oral Oncol.
2002;38:323-31.
http://dx.doi.org/10.1016/S1368-8375(01)00066-5
PMid:12076694
|
|
|
|
9. Crowley TE, Kaugars GE, Gunsolley JC. Odontogenic keratocysts: a
clinical and histologic comparison of the parakeratin and orthokeratin
variants. J
Oral Maxillofac Surg.
1992;50:22-6.
http://dx.doi.org/10.1016/0278-2391(92)90187-5
PMid:1370082
|
|
|
|
10. Zhao YF, Wei JX,
Wang SP. Treatment of odontogenic keratocysts: a follow-up of 255 Chinese patients. Oral Surg Oral Med Oral Pathol
Oral Radiol Endod. 2002;94:151-6.
http://dx.doi.org/10.1067/moe.2001.125694
PMid:12221380
|
|
|
|
11. Forssell
K, Forssell H, Kahnberg
KE. Recurrence of keratocysts. A long-term
follow-up study. Int J Oral Maxillofac
Surg. 1988;17:25-8.
http://dx.doi.org/10.1016/S0901-5027(88)80224-8
PMid:3127485
|
|
|
|
12. Langdon JD,
Partridge M. Expression of the tumour suppressor
gene p53 in oral cancer. Br J Oral Maxillofac Surg. 1992;30:214-20.
http://dx.doi.org/10.1016/0266-4356(92)90263-I
PMid:1380822
|
|
|
|
13. Miller C, Mohandas
T, Wolf D, Prokocimer M, Rotter
V, Koeffler HP. Human p53 gene localized to short
arm of chromosome 17. Nature. 1986;319:783-4.
http://dx.doi.org/10.1038/319783a0
PMid:3005871
|
|
|
|
14. Piattelli
A, Fioroni M, Santinelli
A, Rubini C. P53 protein expression in odontogenic cysts. J Endod.
2001;27:459-61.
http://dx.doi.org/10.1097/00004770-200107000-00006
PMid:11503996
|
|
|
|
15.
Gurgel CA, Ramos EA, Azevedo
RA, Sarmento VA, da Silva Carvalho AM, dos Santos
JN. Expression of Ki-67, p53 and p63 proteins in keratocyst odontogenic tumours: an immunohistochemical
study. J
Mol Histol. 2008;39:311-6.
http://dx.doi.org/10.1007/s10735-008-9167-0
PMid:18256893
|
|
|
|
16. Trink
B, Okami K, Wu L, Sriuranpong
V, Jen J, Sidransky D. A new human p53 homologue.
Nat Med. 1998;4:747-8.
http://dx.doi.org/10.1038/nm0798-747
PMid:9662346
|
|
|
|
17. Lo Muzio L, Santarelli A, Caltabiano R, Rubini C, Pieramici T, Giannone N, et
al. p63 expression correlates with pathological features and biological behaviour of odontogenic tumours. Histopathology. 2006;49:211-4.
http://dx.doi.org/10.1111/j.1365-2559.2006.02423.x
PMid:16879406
|
|
|
|
18. Dotsch
V, Bernassola F, Coutandin
D, Candi E, Melino G.
p63 and p73, the ancestors of p53. Cold Spring Harb
Perspect Biol. 2010;2:a004887.
http://dx.doi.org/10.1101/cshperspect.a004887
PMid:20484388 PMCid:PMC2926756
|
|
|
|
19. Potente
M, Gerhardt H, Carmeliet P. Basic and therapeutic
aspects of angiogenesis. Cell. 2011;146:873-87.
http://dx.doi.org/10.1016/j.cell.2011.08.039
PMid:21925313
|
|
|
|
20.
Lo Muzio L, Santarelli
A, Caltabiano R, Rubini
C, Pieramici T, Fior A,
et al. p63 expression in odontogenic
cysts. Int J Oral Maxillofac Surg. 2005;34:668-73.
http://dx.doi.org/10.1016/j.ijom.2004.12.002
PMid:16053892
|
|
|
|
21. Weidner N, Semple JP, Welch WR, Folkman
J. Tumor angiogenesis and metastasis--correlation in invasive breast
carcinoma. N Engl J Med. 1991;324:1-8.
http://dx.doi.org/10.1056/NEJM199101033240101
PMid:1701519
|
|
|
|
22. Sappayatosok
K, Maneerat Y, Swasdison
S, Viriyavejakul P, Dhanuthai
K, Zwang J, et al. Expression of pro-inflammatory
protein, iNOS, VEGF and COX-2 in oral squamous cell carcinoma (OSCC), relationship with
angiogenesis and their clinico-pathological
correlation. Med Oral Patol Oral Cir Bucal. 2009;14:E319-24.
PMid:19300368
|
|
|
|
23. Ball VA, Righi PD, Tejada E, Radpour S, Pavelic ZP, Gluckman JL. p53 immunostaining of surgical margins as a predictor of
local recurrence in squamous cell carcinoma of
the oral cavity and oropharynx. Ear Nose Throat J. 1997;76:818-23.
PMid:9397628
|
|
|
|
24.
Lo Muzio L, Campisi G, Farina A, Rubini C, Pastore
L, Giannone N, et al. Effect of p63 expression on survival in oral squamous
cell carcinoma. Cancer Invest. 2007;25:464-9.
http://dx.doi.org/10.1080/07357900701509387
PMid:17882659
|
|
|
|
25. Benard
J, Douc-Rasy S, Ahomadegbe
JC. TP53 family members and human cancers. Hum Mutat. 2003;21:182-91.
http://dx.doi.org/10.1002/humu.10172
PMid:12619104
|
|
|
|
26. Varsha
B, Gharat AL, Nagamalini
B, Jyothsna M, Mothkur
ST, Swaminathan U. Evaluation and comparison of
expression of p63 in odontogenic keratocyst, solid ameloblastoma
and unicystic ameloblastoma.
J Oral Maxillofac Pathol.
2014;18:223-8.
http://dx.doi.org/10.4103/0973-029X.140755
PMid:25328303 PMCid:PMC4196291
|
|
|
|
27. Li TJ, Browne RM,
Prime SS, Paterson IC, Matthews JB. p53 expression
in odontogenic keratocyst
epithelium. J Oral Pathol Med. 1996;25:249-55.
http://dx.doi.org/10.1111/j.1600-0714.1996.tb01380.x
PMid:8835823
|
|
|
|
28. Liu L, Cui X, Sakaguchi T, Sasaki M, Suda T,
Hatakeyama K. Expression of p73 in colorectal
carcinoma: clinicopathological relevance. J Int Med Res. 2001;29:297-303.
http://dx.doi.org/10.1177/147323000102900406
PMid:11675903
|
|
|
|
29. Kademani
D, Lewis JT, Lamb DH, Rallis DJ, Harrington JR. Angiogenesis and CD34
expression as a predictor of recurrence in oral squamous
cell carcinoma. J Oral Maxillofac Surg. 2009;67:1800-5.
http://dx.doi.org/10.1016/j.joms.2008.06.081
PMid:19686913
|
30. Gadbail
AR, Hande A, Chaudhary M,
Nikam A, Gawande M, Patil S, et al. Tumor angiogenesis in keratocystic
odontogenic tumor assessed by using CD-105 antigen.
J Oral Pathol Med. 2011;40:263-9.
http://dx.doi.org/10.1111/j.1600-0714.2010.00962.x
PMid:20969632
|